Literature DB >> 6979212

Computed tomography of ureteral obstruction.

M A Bosniak, A J Megibow, M A Ambos, J S Mitnick, R S Lefleur, R Gordon.   

Abstract

Although hydronephrosis can usually be diagnosed by urography and/or pyelography, the etiology of the obstruction may not be apparent. Computed tomography (CT) is usually helpful in evaluation of these cases. In 36 cases in which CT was performed solely to determine the cause of ureteral obstruction of uncertain etiology, it proved to be of value in 33 instances (91.7%). The disease processes encountered in this series included metastatic carcinoma to the ureter or periureteral tissues(22), lymphoma (one), primary ureteral tumor (two), radiolucent ureteral stone (four), adjacent ileocolitis (two), aortic or iliac artery aneurysm (two), fibrous band(one), urinoma (one), and radiation fibrosis (one). In three cases (8.3%) an etiologic diagnosis could not be made by CT. These patients had radiation therapy to treat malignant disease, and recurrent tumor responsible for ureteral obstruction could not be distinguished from radiation fibrosis.

Entities:  

Mesh:

Year:  1982        PMID: 6979212     DOI: 10.2214/ajr.138.6.1107

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

1.  Computed tomography evaluation of local and extraintestinal complications of Crohn's disease.

Authors:  G W Kerber; M Greenberg; J M Rubin
Journal:  Gastrointest Radiol       Date:  1984

2.  Metastatic disease of the ureter: patterns of tumoral spread and radiologic findings.

Authors:  B Marincek; J R Scheidegger; U E Studer; R Kraft
Journal:  Abdom Imaging       Date:  1993

3.  Ureteral lymphoma: MRI demonstration.

Authors:  J A Lebowitz; N M Rofsky; J C Weinreb; P Friedmann
Journal:  Abdom Imaging       Date:  1995 Mar-Apr

4.  Metastatic ureteral involvement of non-small cell lung cancer.

Authors:  Koichi Kodama; Tetsuya Imao; Kazuto Komatsu
Journal:  Case Rep Med       Date:  2011-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.